Zeller, Mitchell https://orcid.org/0009-0002-1461-6028
Article History
Received: 18 July 2023
Accepted: 28 July 2023
First Online: 7 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: The author of this commentary is currently an advisor to Qnovia, a start-up pharmaceutical company developing an inhaled smoking cessation product that it intends to seek authorization for marketing in the United States.